Cardiovascular outcomes of continuous positive airway pressure therapy for obstructive sleep apnea
- PMID: 30687542
- PMCID: PMC6321890
- DOI: 10.21037/jtd.2018.11.48
Cardiovascular outcomes of continuous positive airway pressure therapy for obstructive sleep apnea
Abstract
Obstructive sleep apnea is a common disorder with increased risk for cardiovascular morbidity and mortality. The first choice of treatment of obstructive sleep apnea is continuous positive airway pressure, which reduces excessive daytime sleepiness and improves quality of life in sleep clinic cohorts. Nevertheless, the majority of patients with cardiovascular disease and concomitant obstructive sleep apnea do not report daytime sleepiness, and adherence to treatment is insufficient particularly in this group. The current article aims to give an updated overview of the impact of continuous positive airway pressure therapy on cardiovascular outcomes mainly based on the observational studies and the recent randomized controlled trials.
Keywords: Obstructive sleep apnea (OSA); cardiovascular outcomes; continuous positive airway pressure (CPAP); randomized controlled trial (RCT).
Conflict of interest statement
Conflicts of Interest: Dr. Y Peker reports grants from ResMed, during the conduct of the RICCADSA study mentioned in the current review; personal fees from BresoTec Inc., and personal fees from Philips-Respironics, outside the submitted work. Dr. B Balcan has no conflicts of interest to declare.
References
-
- Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012;8:597-619. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources